INSIGHTS ON QUALITY CONTROL

• Platform Strategy For Improving Manufacturability And Efficacy In Bispecific Antibodies

  Novel bispecific antibody engineering overcomes assembly and manufacturability challenges, enabling scalable production while preserving therapeutic function, stability, purity, and product quality.

• Activate Advanced Contamination Control Technology To Safeguard Your Cell Therapy

  The most common contamination risks in cell therapy manufacturing are open processes that leverage different products, inflexible instruments, labor intensive workflows, lack of in-line monitoring, and zero failure tolerance.

• Building A Science- And Risk-Based Bio-Decontamination Strategy

  Annex 1 has made bio-decontamination central to sterility assurance, with isolator and barrier cycles now expected to be designed, justified, and reviewed across their lifecycle.

• Aseptic Filling Quality Through Precision

  Precise measurement shapes every reliable workcell. Meet Andrew, a specialist who verifies components with micron‑level accuracy, ensuring each piece is built to perform exactly as designed.

• LYO Cycle Development Ensures Success For Oncology Drug Scale-Up

  5/14/2026

  An optimized lyophilization cycle removes excess moisture during scale‑up by adjusting drying for larger equipment, improving stability, maintaining efficiency, and supporting clinical validation.

• Eliminate Variability, Accelerate Results: Value Of Ready-To-Use Reagents

  10/15/2026

  Pre-made solutions reduce operator variability, save bench time, and lower contamination risk by eliminating reagent preparation and reducing handling.

• Contamination Control Strategy With QRM Principles

  11/19/2024

  Contamination Control Strategies (CCS) have long been a main concept, but advancing requirements and regulatory expectations create a challenge. Learn how to be effective and compliant with your CCS.

• Safety Of Injectables: Ensuring Purity Via Endotoxin Testing

  7/28/2026

  Advance pharmaceutical quality and sustainability by adopting recombinant factor C testing for reliable, animal-free endotoxin detection.

• How Do You Navigate GxP Compliance?

  4/21/2026

  Heightened FDA scrutiny demands a shift from fragmented data to unified digital systems. Learn how to automate QA tasks, secure data integrity, and maintain a constant state of inspection readiness.